View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsWellfully 将来の成長Future 基準チェック /06現在、 Wellfullyの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Pharmaceuticals 収益成長40.7%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Mar 28Wellfully Limited, Annual General Meeting, Apr 26, 2024Wellfully Limited, Annual General Meeting, Apr 26, 2024, at 10:00 W. Australia Standard Time. Location: Pitcher Partners, Level 11, 12 The Esplanade Perth Australiaお知らせ • Jun 09Wellfully Limited Announces Board ChangesThe Board of Wellfully Limited announced that Miss Clothier has been appointed as Non-Executive Director, effective 9 June 2023 and Blagojce (Bill) Pavlovski as Non-Executive Director and Company Secretary, effective 9 June 2023. About Lea Clothier: Lea has a 20+ year background in personal finance in Australia and the US. A former award-winning Financial Adviser and social entrepreneur, Lea has formal qualifications in Business Management, Financial Planning, Coaching, Behavioural Finance, Well-being and Mindfulness. Lea is a values-driven professional woman constantly seeking to improve and create efficiencies, "work smarter, not harder", innovate and think outside the box. She passionately advocates for Wellbeing, Social Enterprise, Mental Health, Financial Capability, Online Learning, Personal Development and Empowerment programs. About Mr. Pavlovski: Mr. Pavlovski holds a Bachelor of Business majoring in Applied Economics and International Trade. Mr. Pavlovski brings 15 years of experience in a career spanning banking, wealth management and corporate advisory services. Mr. Pavlovski is also an Investment and Corporate advisor one of Australia's most active stockbroking and corporate advisory firms specialising in small to medium high growth companies. Mr. Pavlovski brings a deep understanding and experience of capital markets gained during a respected career. He has the relevant skills to make valuable contributions to the Board of WFL. Coinciding with Miss Clothier and Mr. Pavlovski's appointments, the Company advises Mr. David Wheeler has resigned from his role as Non-Executive Director to focus on his other business interests and directorships. Furthermore, Mr. Tim Slate will be stepping down from his role as Company Secretary.お知らせ • May 19Wellfully Limited Appoints John Forrester as DirectorWellfully Limited announced the appointment of John Forrester as Director of the company with effect from 18 May 2023.Reported Earnings • Apr 11First half 2023 earnings released: AU$0.015 loss per share (vs AU$0.019 loss in 1H 2022)First half 2023 results: AU$0.015 loss per share. Revenue: AU$276.9k (down 78% from 1H 2022). Net loss: AU$4.81m (loss widened 12% from 1H 2022).お知らせ • Jan 09Wellfully Limited Appoints David Wheeler as Non-Executive Director, Effective from 1 February 2023Wellfully Limited announced an update to the Board. Mr. David Wheeler has been appointed as a Non-executive Director effective 1 February 2023. David comes from a background of more than 30 years of Senior Executive Management, Directorships, and Corporate Advisory experience. He is a foundation Director and Partner of Pathways Corporate a Corporate Advisory firm that undertakes assignments on behalf of family offices, private clients, and ASX listed companies. David has engaged in business projects in the USA, UK, Europe, NZ, China, Malaysia, Singapore and the Middle East. David is a Fellow of the Australian Institute of Company Directors and has experience on public and private company boards, currently holding a number of Directorships and Advisory positions in Australian companies.お知らせ • Dec 31Wellfully Limited Announces Step Down of Steven Schapera as Non-Executive Director, Effective 31 December 2022Wellfully Limited announced that Mr. Steven Schapera has decided to step down as Non-executive Director effective 31 December 2022.お知らせ • Dec 08Wellfully Limited (ASX:WFL) entered into a non-binding MOU to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million.Wellfully Limited (ASX:WFL) entered into a non-binding MOU to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million on December 6, 2022. The transaction is currently in evaluation, and may be subject to subsequent shareholder approvals in respect of the proposed earn-out. Capital D Management LLP will seek a reduction of the liabilities of TBB prior to the transaction, from AUD1.6 million to AUD0.8 million. Capital D will be offered one Non-Executive Director position on Wellfully’s Board of Directors. TBB generated sales revenue of AUD 12.2 million in the 12 months ending September 2022. The transaction is expected to close in the coming weeks.お知らせ • Nov 18Wellfully Limited Appoints Andy Wortlock as Non-Executive DirectorWellfully Limited announced the appointment of Mr. Andy Wortlock as a Non-Executive Director of the Company. Mr. Wortlock, is a long-term shareholder of Wellfully, and the current Board believes that this appointment will further strengthen the alignment of interests between the Board and shareholders during this dynamic growth phase. In addition to his experience and skillset in international sales, marketing and finance, Mr.Wortlock has earned a solid reputation as a business consultant and executive coach with Adelaide-based Lockley Consulting. He has Sales and Marketing experience in a number of areas that are relevant to the commercial activities of Wellfully, including exposure to the European consumer space, and for these reasons the Board expects that Mr.Wortlock will add, and unlock, additional value as an NED at Wellfully. Through his professional career, Mr. Wortlock has acted as Sales Director forEurope/UK/UAE for Orbitkey, managed the business of Kingdomcity, acted as anexecutive coach with Lockley Consulting, and co-founded May Home Store - a homeand wellness business. Mr. Wortlock holds a diploma in Financial Services, Advanced Certificates in Business and Professional Coaching, and as Behaviour Profiling. He resides in Adelaide, Australia and does not currently serve as director for any other public listed company.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Steven Schapera was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Oct 21Wellfully Limited, Annual General Meeting, Nov 25, 2022Wellfully Limited, Annual General Meeting, Nov 25, 2022, at 10:00 W. Australia Standard Time. Location: RSM Partners Australia, Level 32 Exchange Tower, 2 The Esplanade Perth Western Australia Australia Agenda: To consider adoption of Remuneration Report; to consider re-election of directors; to consider approval of additional placement facility; to consider issue of new options; and to consider issue of Incentive Performance Rights to Mr. Paul Peros.Reported Earnings • Oct 04Full year 2022 earnings released: AU$0.031 loss per share (vs AU$0.041 loss in FY 2021)Full year 2022 results: AU$0.031 loss per share. Revenue: AU$2.64m (up 119% from FY 2021). Net loss: AU$7.30m (loss widened 14% from FY 2021).Reported Earnings • Sep 01Full year 2022 earnings released: AU$0.034 loss per share (vs AU$0.041 loss in FY 2021)Full year 2022 results: AU$0.034 loss per share. Revenue: AU$2.60m (up 116% from FY 2021). Net loss: AU$8.07m (loss widened 26% from FY 2021).お知らせ • Aug 12Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.136528 million.Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.136528 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,537,000 Price\Range: AUD 0.0386 Transaction Features: Subsequent Direct Listingお知らせ • Aug 03Wellfully Limited Announces Knee Patch Registered as A Medical DeviceWellfully Limited announced that the Swisswell Knee PatchTM has been successfully registered as a medical device in Australia, effective August 2nd, 2022. The Swisswell Knee Patch has been registered with the TGA as a medicaldevice in Australia The Australian topical pain relief market is valued at USD 725 million. Registration as a medical device enables substantiated medical claims to be made, significantly broadening roll-out opportunities beyond just pharmacy partners across Australia. The Swisswell Knee PatchTM was first test-launched in August 2021, but only sold through the Company's DTC (direct-to-consumer) channels as an unregistered medical device without any medical claims. Initial feedback from consumers, as well as interest from potential distribution partners, has been most positive. With this registration, Wellfully is now able to freely engage with retail partners andspecialist distributors in the Australian market, enabling a broad scale marketing effort that can include substantiated medical claims.お知らせ • Jul 11Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.1 million.Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,000,000 Price\Range: AUD 0.05 Transaction Features: Subsequent Direct Listingお知らせ • Jul 08Wellfully Limited announced that it expects to receive AUD 0.1 million in fundingWellfully Limited announced a private placement of 2,000,000 shares at a price of AUD 0.05 per share for gross proceeds of AUD 100,000 on July 8, 2022. The transaction will include participation from certain existing shareholders who are professional, sophisticated and section 708 exempt investors, none of whom are directors or related parties.お知らせ • Jul 07Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.13 million.Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.13 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,600,000 Price\Range: AUD 0.05 Transaction Features: Subsequent Direct Listingお知らせ • May 26Wellfully Limited Announces Board ChangesWellfully Limited announced changes in Board composition and total non-executive remuneration. Mr. Antonio Varano della Vergiliana to retire from the Board of Directors of the Company, effective from 30 June 2022; Mr. Varano, who has been with the Company since May 2019 and had been acting in the role of Chairman up until April 2022 has retired as a Director of the Company effective 30 June 2022. The Board of Wellfully would like to acknowledge and thank Mr. Varano for his dedication and contribution during his tenure as Chairman of the Board and Board member. Mr. Varano has led the Company through its critical transformation towards becoming a fully-integrated science-based company, through the difficulties of the COVID pandemic, and all its challenges. His proven leadership and strategic vision have allowed the Company to reach its current development phase. Now that the Company is entering a more operational phase of its further development Mr. Varano will turn his focus and energy to other endeavours.お知らせ • Apr 27Wellfully Limited Announces Swisswell Knee Patch Successfully Registered as Medical Device in the USAWellfully Limited announced that the Swisswell Knee Patch has been successfully registered as a medical device in the USA, effective April 22th, 2022. The Swisswell Knee Patch was initially launched in August 2021, but only sold through the Company's DTC (direct-to-consumer) channels. Initial feedback from consumers, and as well as interest from potential industry partners, has been most positive. A number of initial collaboration evaluations have been initiated across several markets through to December 2021. With this FDA registration the Company will now be able to execute on existing collaborations, as well as engage with new partners and distributors across the US market. This can now be done on a wider scale (in terms of both marketing and distribution) as compared to the earlier cosmetics device registration awarded January 2022. Importantly, the medical registration allows for substantiated pain relief claims to be made by both the Company and its specialist retailers (especially pharmacies). The Company will use the FDA registration, as well as the earlier EUDAMED medical device registration and CPNP cosmetics device registration, to support necessary regulatory approvals in other important markets including the UK and Australia.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Tony Vergiliana was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 21Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Tony Vergiliana was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 14Wellfully Limited Announces Board ChangesWellfully Limited announced a number of Board changes: Mr. Varano, who has been with the Company since May 2018, and acting in the role of Chairman since June 2018, has vacated the role of Chairman and will continue as aNon-Executive Director of the Company. Mr. Peros, the Company's CEO, has been appointed as Executive Chairman. Mr. Peros joined the Company in June 2019. Since then, his role has transformed from management to one of leadership. The Board recognises Mr. Peros' ability to not only to execute but also to direct the Company towards achieving its commercial objectives. As a substantial shareholder in the Company, this appointment also reflects thealignment of Mr.Peros' interest in growing the Company and creating value for all shareholders. Mr. Peros terms of employment remains unchanged following the above appointment. Mr. Eaton has been appointed as Non-Executive Director. Mr. Eaton co-founded the corporate and commercial law firm Eaton Hall in 2014. He specialises in providing corporate advice to ASX listed companies, with a particular focus on the innovation and technology, agribusiness, and energy and resources sectors. Mr. Eaton currently acts as legal council for the Company. Concurrent with Mr.Eaton's appointment, the Company advises of the resignation of Mr. Wright as non-executive director. Mr. Wright has tendered his resignation in order to pursue other business opportunities.Reported Earnings • Mar 06First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: AU$0.019 loss per share (up from AU$0.025 loss in 1H 2021). Revenue: AU$1.25m (up 20% from 1H 2021). Net loss: AU$4.31m (loss widened 32% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has fallen by 46% per year, which means it is performing significantly worse than earnings.Executive Departure • Dec 03Independent Non-Executive Director Cameron Reynolds has left the companyOn the 1st of December, Cameron Reynolds' tenure as Independent Non-Executive Director ended after 3.4 years in the role. As of September 2021, Cameron still personally held 829.17k shares (AU$145k worth at the time). Cameron is the only executive to leave the company over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model.Reported Earnings • Oct 04Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: AU$1.20m (down 19% from FY 2020). Net loss: AU$6.40m (loss widened 72% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings.Reported Earnings • Sep 03Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: AU$1.20m (down 19% from FY 2020). Net loss: AU$6.40m (loss widened 72% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 34% per year whereas the company’s share price has fallen by 36% per year.お知らせ • Feb 11Wellfully Limited announced that it expects to receive AUD 4.75 million in fundingWellfully Limited (ASX:WFL) announced a private placement of up to 63,333,334 shares at an issue price of AUD 0.075 per share for gross proceeds of up to AUD 4,750,000 on February 9, 2021. The transaction will include participation from sophisticated and professional investors including Jeffrey Edwards for up to 500,000 shares, Cameron Reynolds for up to 500,000 shares, Steven Schapera for up to 500,000 shares and Antonio Varano for up to 500,000 shares. The company will receive funding in two tranches, the first tranche of 21,973,070 shares is expected to be close on February 10, 2021 and second and final tranche of remaining 41,360,264 shares expected to be close on March 23, 2021. The transaction is subject to the shareholders approval in a general meeting to be held on March 22, 2021.お知らせ • Feb 10Wellfully Limited has announced a Derivatives Offering in the amount of AUD 0.112307 million.Wellfully Limited has announced a Derivatives Offering in the amount of AUD 0.112307 million. Security Name: Options Security Type: Equity Option Securities Offered: 112,306,802 Price\Range: AUD 0.001 Discount Per Security: AUD 0.00006 Transaction Features: Rights Offeringお知らせ • Feb 08Wellfully Limited Announces Business & Operational UpdateWellfully Limited provided shareholders and interested parties with an update on operational progress within the business as it enters trading halt to undergo a capital raising. Swiss Laboratories and Plant: Purpose: Competence center for pod topicals, RÉDUIT and Swisswell (Bodyguard); development and manufacturing activities; "Swiss Made" claim substantiation. Status: Secured location and space (Bioggio, Switzerland); incorporated local entity (Swisswell Sagl); defined, sourced and shipped all bulk production, filling and related water preparation and clean room equipment to the site. Next: Laboratory and factory set-up; and go-live commissioning. New RÉDUIT UNI Product Line; Purpose: Competitive applicator device to further aid system adoption; more competitive price point (approx $100); wider application spectrum (hair and skin) and advanced ergonomics (bi-directional pod insertion, 2-speed operation). Status: Development, tooling and industrialisation completed (T0, T1 and T2); first shipping of product planned for end of February 2021. Next: Go-to-market activities; preparation of communication assets (product, model and lifestyle shots, explainer video/animation); launch communication campaigns (PR, advertising). SWISSWELL Lubricen: Purpose: Launch of the Bodyguard kneepatch under Wellfully's Swisswell brand platform; first of advanced delivery health and wellness products from Wellfully to reach the market. Status: Industrial tests for the patched performed; initial product assets (design, graphics) and infrastructure (website, order system) completed; market compliance approval initiated. Next: Completion of brand assets; initial production (samples, first commercial products); launch campaign execution. RÉDUIT Commercial Development; Purpose: Increase the footprint of the brand and gain commercial scale sales. Status: Launch with The Hut Group, Douglas (Poland). Next: Launch with Cult Beauty in Feb-Mar 2021, ongoing discussions with Sephora (China and US) and ULTA (US). DOLCE CANN Cannabinoids; Purpose: Secure high-performance anti-inflammatory actives for both beauty and health products. Status: Initiated R&D activities (testing of samples). Next: Completion of R&D activities, definition of initial product development portfolio (skincare and health products) and initiation of execution. In-situ Separation of Mixtures: Purpose: Development of first-of-a-kind high-performance skincare emulsions. Status: Patent granted, initial product concepts developed. Next: Product development and industrialisation. Hygiene Product Range: Purpose: Unique at-home disinfecting product that does not rely on aggressive chemical ingredients, but in-situ electrolysis in order to generate disinfectant from water, salt and brine at the point of use. This is delivered with Wellfully's enhanced delivery technologies for better application effectiveness. Status: Basic product architecture defined, specific models developed and tested for operating logic. Next: Industrialisation, tooling, first production, go-to-market planning and execution. Wellfully Ambassador Program: Purpose: Development of own B2B2C and B2C2C network including digital and communication infrastructure in order to improve access to consumers in COVID-19 impacted markets. Status: Initial support systems and go-live completed between Dec. 2020 and Jan. 2021 across selected markets (UK and Switzerland). Next: Program fine-tuning, additional systems development and wider roll-out of the program.お知らせ • Oct 13Wellfully Limited Completes Its Scheduled Release of 20 Launches in 20 Weeks for Its RÉDUIT BrandWellfully Limited announced that it has completed its scheduled release of 20 launches in 20 weeks for its RÉDUIT brand. This means since June 2020 the brand has now launched six new applicator devices and a total of 24 premium cosmetic products across the haircare and skincare categories, with 12 HairpodsTM and 12 SkinpodsTM. The ambitious project was a test of the Company's ability to incubate technology, execute on development and launch. It also catalyzed the securement of global e-commerce B2B partners such as The Hut Group and Current Body, and was timed to coincide with the launch of a redesigned reduit.com aimed to educate and convert B2C customers.Reported Earnings • Oct 04Full year earnings released - AU$0.041 loss per shareOver the last 12 months the company has reported total losses of AU$3.71m, with losses widening by 117% from the prior year. Total revenue was AU$1.48m over the last 12 months, down 46% from the prior year.お知らせ • Sep 24Wellfully Limited Signs A Content Partnership for Its RÉDUIT Brand with Victoria BeckhamWellfully Limited announced it has signed a content partnership for its RÉDUIT brand with one of the world's most reputable fashion and celebrity labels, Victoria Beckham. The collaboration will enable RÉDUIT to continue its brand awareness growth strategies and instill credibility by way of association with a globally renowned name. The alliance sees RÉDUIT as the official hair tech partner for the Victoria Beckham Spring Summer 2021 Collection Presentation at London Fashion Week. The partnership allows content creation backstage of the show whereby RÉDUIT One Gold devices and the LED HairpodTM collection will be used by celebrity hair stylist, Paul Hanlon, to prepare models before the runway. The term of the agreement is to 18 October 2020. Additionally, any assets created in accordance with the Sponsorship Rights may be used up to and including 17 September 2021 provided they make clear reference to the SS21 collection. Terms and Conditions are standard for sponsorship agreements of this kind, a one-off payment from the Company to Victoria Beckham is deemed not material and there are no other material terms to be satisfied before the agreement proceeds.お知らせ • Sep 18Wellfully Limited Agrees to Supply Terms For, and Launches its Réduit Brand with The Hut GroupWellfully Limited announced it has agreed to supply terms for, and is launching, its RÉDUIT brand with The Hut Group (THG). The collaboration will enable RÉDUIT to continue its market expansion and growth strategy. The alliance will expose the brand to THG's e-commerce network covering market-leading platforms such as lookfantastic.com, hqhair.com. skinstore.com and ry.com.au, with a consumer reach of over 12 million1 premium beauty visitors per month across the globe. With revenues of approximately GBP 1.14 billion2, THG is one of the large beauty e-commerce operators globally with a substantial expertise in the device and beauty technology category. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Wellfully は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測ASX:WFL - アナリストの将来予測と過去の財務データ ( )AUD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20222-8-6-6N/A9/30/20222-8-7-7N/A6/30/20223-7-8-8N/A3/31/20222-7-7-7N/A12/31/20211-7-7-6N/A9/30/20211-7-6-6N/A6/30/20211-6-5-5N/A3/31/20211-6-5-5N/A12/31/20201-6-5-5N/A9/30/20201-5-4-4N/A6/30/20201-4-3-3N/A3/31/20202-3-2-2N/A12/31/20193-2-2-2N/A9/30/20193-2-2-2N/A6/30/20193-2-2-2N/A3/31/20192-2-2-2N/A12/31/20182-2-2-2N/A9/30/20182-2-2-2N/A6/30/20182-2-1-1N/A3/31/20182-1-1-1N/A12/31/20172-1-1-1N/A9/30/20172-2-1-1N/A6/30/20172-3-2-2N/A3/31/20172-4-2-2N/A12/31/20162-5-3-2N/A9/30/20162-4N/A-2N/A6/30/20162-4N/A-2N/A3/31/20162-3N/A-2N/A12/31/20152-3N/A-3N/A9/30/20152-3N/A-2N/A6/30/20152-2N/A-2N/A3/31/20151-2N/A-2N/A12/31/20141-2N/A-2N/A9/30/20141-2N/A-2N/A6/30/20141-2N/A-2N/A3/31/20141-2N/A-1N/A12/31/20131-1N/A-1N/A9/30/20131-1N/A-1N/A6/30/20131-1N/A-1N/A3/31/20131-2N/A-1N/A12/31/20120-2N/A-1N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: WFLの予測収益成長が 貯蓄率 ( 2% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: WFLの収益がAustralian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: WFLの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: WFLの収益がAustralian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: WFLの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: WFLの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/10/18 00:32終値2023/07/21 00:00収益2022/12/31年間収益2022/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Wellfully Limited これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Mar 28Wellfully Limited, Annual General Meeting, Apr 26, 2024Wellfully Limited, Annual General Meeting, Apr 26, 2024, at 10:00 W. Australia Standard Time. Location: Pitcher Partners, Level 11, 12 The Esplanade Perth Australia
お知らせ • Jun 09Wellfully Limited Announces Board ChangesThe Board of Wellfully Limited announced that Miss Clothier has been appointed as Non-Executive Director, effective 9 June 2023 and Blagojce (Bill) Pavlovski as Non-Executive Director and Company Secretary, effective 9 June 2023. About Lea Clothier: Lea has a 20+ year background in personal finance in Australia and the US. A former award-winning Financial Adviser and social entrepreneur, Lea has formal qualifications in Business Management, Financial Planning, Coaching, Behavioural Finance, Well-being and Mindfulness. Lea is a values-driven professional woman constantly seeking to improve and create efficiencies, "work smarter, not harder", innovate and think outside the box. She passionately advocates for Wellbeing, Social Enterprise, Mental Health, Financial Capability, Online Learning, Personal Development and Empowerment programs. About Mr. Pavlovski: Mr. Pavlovski holds a Bachelor of Business majoring in Applied Economics and International Trade. Mr. Pavlovski brings 15 years of experience in a career spanning banking, wealth management and corporate advisory services. Mr. Pavlovski is also an Investment and Corporate advisor one of Australia's most active stockbroking and corporate advisory firms specialising in small to medium high growth companies. Mr. Pavlovski brings a deep understanding and experience of capital markets gained during a respected career. He has the relevant skills to make valuable contributions to the Board of WFL. Coinciding with Miss Clothier and Mr. Pavlovski's appointments, the Company advises Mr. David Wheeler has resigned from his role as Non-Executive Director to focus on his other business interests and directorships. Furthermore, Mr. Tim Slate will be stepping down from his role as Company Secretary.
お知らせ • May 19Wellfully Limited Appoints John Forrester as DirectorWellfully Limited announced the appointment of John Forrester as Director of the company with effect from 18 May 2023.
Reported Earnings • Apr 11First half 2023 earnings released: AU$0.015 loss per share (vs AU$0.019 loss in 1H 2022)First half 2023 results: AU$0.015 loss per share. Revenue: AU$276.9k (down 78% from 1H 2022). Net loss: AU$4.81m (loss widened 12% from 1H 2022).
お知らせ • Jan 09Wellfully Limited Appoints David Wheeler as Non-Executive Director, Effective from 1 February 2023Wellfully Limited announced an update to the Board. Mr. David Wheeler has been appointed as a Non-executive Director effective 1 February 2023. David comes from a background of more than 30 years of Senior Executive Management, Directorships, and Corporate Advisory experience. He is a foundation Director and Partner of Pathways Corporate a Corporate Advisory firm that undertakes assignments on behalf of family offices, private clients, and ASX listed companies. David has engaged in business projects in the USA, UK, Europe, NZ, China, Malaysia, Singapore and the Middle East. David is a Fellow of the Australian Institute of Company Directors and has experience on public and private company boards, currently holding a number of Directorships and Advisory positions in Australian companies.
お知らせ • Dec 31Wellfully Limited Announces Step Down of Steven Schapera as Non-Executive Director, Effective 31 December 2022Wellfully Limited announced that Mr. Steven Schapera has decided to step down as Non-executive Director effective 31 December 2022.
お知らせ • Dec 08Wellfully Limited (ASX:WFL) entered into a non-binding MOU to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million.Wellfully Limited (ASX:WFL) entered into a non-binding MOU to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million on December 6, 2022. The transaction is currently in evaluation, and may be subject to subsequent shareholder approvals in respect of the proposed earn-out. Capital D Management LLP will seek a reduction of the liabilities of TBB prior to the transaction, from AUD1.6 million to AUD0.8 million. Capital D will be offered one Non-Executive Director position on Wellfully’s Board of Directors. TBB generated sales revenue of AUD 12.2 million in the 12 months ending September 2022. The transaction is expected to close in the coming weeks.
お知らせ • Nov 18Wellfully Limited Appoints Andy Wortlock as Non-Executive DirectorWellfully Limited announced the appointment of Mr. Andy Wortlock as a Non-Executive Director of the Company. Mr. Wortlock, is a long-term shareholder of Wellfully, and the current Board believes that this appointment will further strengthen the alignment of interests between the Board and shareholders during this dynamic growth phase. In addition to his experience and skillset in international sales, marketing and finance, Mr.Wortlock has earned a solid reputation as a business consultant and executive coach with Adelaide-based Lockley Consulting. He has Sales and Marketing experience in a number of areas that are relevant to the commercial activities of Wellfully, including exposure to the European consumer space, and for these reasons the Board expects that Mr.Wortlock will add, and unlock, additional value as an NED at Wellfully. Through his professional career, Mr. Wortlock has acted as Sales Director forEurope/UK/UAE for Orbitkey, managed the business of Kingdomcity, acted as anexecutive coach with Lockley Consulting, and co-founded May Home Store - a homeand wellness business. Mr. Wortlock holds a diploma in Financial Services, Advanced Certificates in Business and Professional Coaching, and as Behaviour Profiling. He resides in Adelaide, Australia and does not currently serve as director for any other public listed company.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Steven Schapera was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 21Wellfully Limited, Annual General Meeting, Nov 25, 2022Wellfully Limited, Annual General Meeting, Nov 25, 2022, at 10:00 W. Australia Standard Time. Location: RSM Partners Australia, Level 32 Exchange Tower, 2 The Esplanade Perth Western Australia Australia Agenda: To consider adoption of Remuneration Report; to consider re-election of directors; to consider approval of additional placement facility; to consider issue of new options; and to consider issue of Incentive Performance Rights to Mr. Paul Peros.
Reported Earnings • Oct 04Full year 2022 earnings released: AU$0.031 loss per share (vs AU$0.041 loss in FY 2021)Full year 2022 results: AU$0.031 loss per share. Revenue: AU$2.64m (up 119% from FY 2021). Net loss: AU$7.30m (loss widened 14% from FY 2021).
Reported Earnings • Sep 01Full year 2022 earnings released: AU$0.034 loss per share (vs AU$0.041 loss in FY 2021)Full year 2022 results: AU$0.034 loss per share. Revenue: AU$2.60m (up 116% from FY 2021). Net loss: AU$8.07m (loss widened 26% from FY 2021).
お知らせ • Aug 12Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.136528 million.Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.136528 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,537,000 Price\Range: AUD 0.0386 Transaction Features: Subsequent Direct Listing
お知らせ • Aug 03Wellfully Limited Announces Knee Patch Registered as A Medical DeviceWellfully Limited announced that the Swisswell Knee PatchTM has been successfully registered as a medical device in Australia, effective August 2nd, 2022. The Swisswell Knee Patch has been registered with the TGA as a medicaldevice in Australia The Australian topical pain relief market is valued at USD 725 million. Registration as a medical device enables substantiated medical claims to be made, significantly broadening roll-out opportunities beyond just pharmacy partners across Australia. The Swisswell Knee PatchTM was first test-launched in August 2021, but only sold through the Company's DTC (direct-to-consumer) channels as an unregistered medical device without any medical claims. Initial feedback from consumers, as well as interest from potential distribution partners, has been most positive. With this registration, Wellfully is now able to freely engage with retail partners andspecialist distributors in the Australian market, enabling a broad scale marketing effort that can include substantiated medical claims.
お知らせ • Jul 11Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.1 million.Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,000,000 Price\Range: AUD 0.05 Transaction Features: Subsequent Direct Listing
お知らせ • Jul 08Wellfully Limited announced that it expects to receive AUD 0.1 million in fundingWellfully Limited announced a private placement of 2,000,000 shares at a price of AUD 0.05 per share for gross proceeds of AUD 100,000 on July 8, 2022. The transaction will include participation from certain existing shareholders who are professional, sophisticated and section 708 exempt investors, none of whom are directors or related parties.
お知らせ • Jul 07Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.13 million.Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.13 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,600,000 Price\Range: AUD 0.05 Transaction Features: Subsequent Direct Listing
お知らせ • May 26Wellfully Limited Announces Board ChangesWellfully Limited announced changes in Board composition and total non-executive remuneration. Mr. Antonio Varano della Vergiliana to retire from the Board of Directors of the Company, effective from 30 June 2022; Mr. Varano, who has been with the Company since May 2019 and had been acting in the role of Chairman up until April 2022 has retired as a Director of the Company effective 30 June 2022. The Board of Wellfully would like to acknowledge and thank Mr. Varano for his dedication and contribution during his tenure as Chairman of the Board and Board member. Mr. Varano has led the Company through its critical transformation towards becoming a fully-integrated science-based company, through the difficulties of the COVID pandemic, and all its challenges. His proven leadership and strategic vision have allowed the Company to reach its current development phase. Now that the Company is entering a more operational phase of its further development Mr. Varano will turn his focus and energy to other endeavours.
お知らせ • Apr 27Wellfully Limited Announces Swisswell Knee Patch Successfully Registered as Medical Device in the USAWellfully Limited announced that the Swisswell Knee Patch has been successfully registered as a medical device in the USA, effective April 22th, 2022. The Swisswell Knee Patch was initially launched in August 2021, but only sold through the Company's DTC (direct-to-consumer) channels. Initial feedback from consumers, and as well as interest from potential industry partners, has been most positive. A number of initial collaboration evaluations have been initiated across several markets through to December 2021. With this FDA registration the Company will now be able to execute on existing collaborations, as well as engage with new partners and distributors across the US market. This can now be done on a wider scale (in terms of both marketing and distribution) as compared to the earlier cosmetics device registration awarded January 2022. Importantly, the medical registration allows for substantiated pain relief claims to be made by both the Company and its specialist retailers (especially pharmacies). The Company will use the FDA registration, as well as the earlier EUDAMED medical device registration and CPNP cosmetics device registration, to support necessary regulatory approvals in other important markets including the UK and Australia.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Tony Vergiliana was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 21Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Tony Vergiliana was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 14Wellfully Limited Announces Board ChangesWellfully Limited announced a number of Board changes: Mr. Varano, who has been with the Company since May 2018, and acting in the role of Chairman since June 2018, has vacated the role of Chairman and will continue as aNon-Executive Director of the Company. Mr. Peros, the Company's CEO, has been appointed as Executive Chairman. Mr. Peros joined the Company in June 2019. Since then, his role has transformed from management to one of leadership. The Board recognises Mr. Peros' ability to not only to execute but also to direct the Company towards achieving its commercial objectives. As a substantial shareholder in the Company, this appointment also reflects thealignment of Mr.Peros' interest in growing the Company and creating value for all shareholders. Mr. Peros terms of employment remains unchanged following the above appointment. Mr. Eaton has been appointed as Non-Executive Director. Mr. Eaton co-founded the corporate and commercial law firm Eaton Hall in 2014. He specialises in providing corporate advice to ASX listed companies, with a particular focus on the innovation and technology, agribusiness, and energy and resources sectors. Mr. Eaton currently acts as legal council for the Company. Concurrent with Mr.Eaton's appointment, the Company advises of the resignation of Mr. Wright as non-executive director. Mr. Wright has tendered his resignation in order to pursue other business opportunities.
Reported Earnings • Mar 06First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: AU$0.019 loss per share (up from AU$0.025 loss in 1H 2021). Revenue: AU$1.25m (up 20% from 1H 2021). Net loss: AU$4.31m (loss widened 32% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has fallen by 46% per year, which means it is performing significantly worse than earnings.
Executive Departure • Dec 03Independent Non-Executive Director Cameron Reynolds has left the companyOn the 1st of December, Cameron Reynolds' tenure as Independent Non-Executive Director ended after 3.4 years in the role. As of September 2021, Cameron still personally held 829.17k shares (AU$145k worth at the time). Cameron is the only executive to leave the company over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model.
Reported Earnings • Oct 04Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: AU$1.20m (down 19% from FY 2020). Net loss: AU$6.40m (loss widened 72% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings.
Reported Earnings • Sep 03Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: AU$1.20m (down 19% from FY 2020). Net loss: AU$6.40m (loss widened 72% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 34% per year whereas the company’s share price has fallen by 36% per year.
お知らせ • Feb 11Wellfully Limited announced that it expects to receive AUD 4.75 million in fundingWellfully Limited (ASX:WFL) announced a private placement of up to 63,333,334 shares at an issue price of AUD 0.075 per share for gross proceeds of up to AUD 4,750,000 on February 9, 2021. The transaction will include participation from sophisticated and professional investors including Jeffrey Edwards for up to 500,000 shares, Cameron Reynolds for up to 500,000 shares, Steven Schapera for up to 500,000 shares and Antonio Varano for up to 500,000 shares. The company will receive funding in two tranches, the first tranche of 21,973,070 shares is expected to be close on February 10, 2021 and second and final tranche of remaining 41,360,264 shares expected to be close on March 23, 2021. The transaction is subject to the shareholders approval in a general meeting to be held on March 22, 2021.
お知らせ • Feb 10Wellfully Limited has announced a Derivatives Offering in the amount of AUD 0.112307 million.Wellfully Limited has announced a Derivatives Offering in the amount of AUD 0.112307 million. Security Name: Options Security Type: Equity Option Securities Offered: 112,306,802 Price\Range: AUD 0.001 Discount Per Security: AUD 0.00006 Transaction Features: Rights Offering
お知らせ • Feb 08Wellfully Limited Announces Business & Operational UpdateWellfully Limited provided shareholders and interested parties with an update on operational progress within the business as it enters trading halt to undergo a capital raising. Swiss Laboratories and Plant: Purpose: Competence center for pod topicals, RÉDUIT and Swisswell (Bodyguard); development and manufacturing activities; "Swiss Made" claim substantiation. Status: Secured location and space (Bioggio, Switzerland); incorporated local entity (Swisswell Sagl); defined, sourced and shipped all bulk production, filling and related water preparation and clean room equipment to the site. Next: Laboratory and factory set-up; and go-live commissioning. New RÉDUIT UNI Product Line; Purpose: Competitive applicator device to further aid system adoption; more competitive price point (approx $100); wider application spectrum (hair and skin) and advanced ergonomics (bi-directional pod insertion, 2-speed operation). Status: Development, tooling and industrialisation completed (T0, T1 and T2); first shipping of product planned for end of February 2021. Next: Go-to-market activities; preparation of communication assets (product, model and lifestyle shots, explainer video/animation); launch communication campaigns (PR, advertising). SWISSWELL Lubricen: Purpose: Launch of the Bodyguard kneepatch under Wellfully's Swisswell brand platform; first of advanced delivery health and wellness products from Wellfully to reach the market. Status: Industrial tests for the patched performed; initial product assets (design, graphics) and infrastructure (website, order system) completed; market compliance approval initiated. Next: Completion of brand assets; initial production (samples, first commercial products); launch campaign execution. RÉDUIT Commercial Development; Purpose: Increase the footprint of the brand and gain commercial scale sales. Status: Launch with The Hut Group, Douglas (Poland). Next: Launch with Cult Beauty in Feb-Mar 2021, ongoing discussions with Sephora (China and US) and ULTA (US). DOLCE CANN Cannabinoids; Purpose: Secure high-performance anti-inflammatory actives for both beauty and health products. Status: Initiated R&D activities (testing of samples). Next: Completion of R&D activities, definition of initial product development portfolio (skincare and health products) and initiation of execution. In-situ Separation of Mixtures: Purpose: Development of first-of-a-kind high-performance skincare emulsions. Status: Patent granted, initial product concepts developed. Next: Product development and industrialisation. Hygiene Product Range: Purpose: Unique at-home disinfecting product that does not rely on aggressive chemical ingredients, but in-situ electrolysis in order to generate disinfectant from water, salt and brine at the point of use. This is delivered with Wellfully's enhanced delivery technologies for better application effectiveness. Status: Basic product architecture defined, specific models developed and tested for operating logic. Next: Industrialisation, tooling, first production, go-to-market planning and execution. Wellfully Ambassador Program: Purpose: Development of own B2B2C and B2C2C network including digital and communication infrastructure in order to improve access to consumers in COVID-19 impacted markets. Status: Initial support systems and go-live completed between Dec. 2020 and Jan. 2021 across selected markets (UK and Switzerland). Next: Program fine-tuning, additional systems development and wider roll-out of the program.
お知らせ • Oct 13Wellfully Limited Completes Its Scheduled Release of 20 Launches in 20 Weeks for Its RÉDUIT BrandWellfully Limited announced that it has completed its scheduled release of 20 launches in 20 weeks for its RÉDUIT brand. This means since June 2020 the brand has now launched six new applicator devices and a total of 24 premium cosmetic products across the haircare and skincare categories, with 12 HairpodsTM and 12 SkinpodsTM. The ambitious project was a test of the Company's ability to incubate technology, execute on development and launch. It also catalyzed the securement of global e-commerce B2B partners such as The Hut Group and Current Body, and was timed to coincide with the launch of a redesigned reduit.com aimed to educate and convert B2C customers.
Reported Earnings • Oct 04Full year earnings released - AU$0.041 loss per shareOver the last 12 months the company has reported total losses of AU$3.71m, with losses widening by 117% from the prior year. Total revenue was AU$1.48m over the last 12 months, down 46% from the prior year.
お知らせ • Sep 24Wellfully Limited Signs A Content Partnership for Its RÉDUIT Brand with Victoria BeckhamWellfully Limited announced it has signed a content partnership for its RÉDUIT brand with one of the world's most reputable fashion and celebrity labels, Victoria Beckham. The collaboration will enable RÉDUIT to continue its brand awareness growth strategies and instill credibility by way of association with a globally renowned name. The alliance sees RÉDUIT as the official hair tech partner for the Victoria Beckham Spring Summer 2021 Collection Presentation at London Fashion Week. The partnership allows content creation backstage of the show whereby RÉDUIT One Gold devices and the LED HairpodTM collection will be used by celebrity hair stylist, Paul Hanlon, to prepare models before the runway. The term of the agreement is to 18 October 2020. Additionally, any assets created in accordance with the Sponsorship Rights may be used up to and including 17 September 2021 provided they make clear reference to the SS21 collection. Terms and Conditions are standard for sponsorship agreements of this kind, a one-off payment from the Company to Victoria Beckham is deemed not material and there are no other material terms to be satisfied before the agreement proceeds.
お知らせ • Sep 18Wellfully Limited Agrees to Supply Terms For, and Launches its Réduit Brand with The Hut GroupWellfully Limited announced it has agreed to supply terms for, and is launching, its RÉDUIT brand with The Hut Group (THG). The collaboration will enable RÉDUIT to continue its market expansion and growth strategy. The alliance will expose the brand to THG's e-commerce network covering market-leading platforms such as lookfantastic.com, hqhair.com. skinstore.com and ry.com.au, with a consumer reach of over 12 million1 premium beauty visitors per month across the globe. With revenues of approximately GBP 1.14 billion2, THG is one of the large beauty e-commerce operators globally with a substantial expertise in the device and beauty technology category.